HEADER TRANSFERASE 20-APR-17 5NQE TITLE HUMAN PARP14 (ARTD8), CATALYTIC FRAGMENT IN COMPLEX WITH AN N-ARYL TITLE 2 PIPERAZINE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLY [ADP-RIBOSE] POLYMERASE 14; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PARP-14,ADP-RIBOSYLTRANSFERASE DIPHTHERIA TOXIN-LIKE 8, COMPND 5 ARTD8,B AGGRESSIVE LYMPHOMA PROTEIN 2; COMPND 6 EC: 2.4.2.30; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PARP14, BAL2, KIAA1268; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: R3 PRARE; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PNIC28-BSA4 KEYWDS ADP-RIBOSYLATION, INHIBITOR COMPLEX, TRANSFERASE DOMAIN, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR T.KARLBERG,A.G.THORSELL,H.SCHULER REVDAT 3 17-JAN-24 5NQE 1 REMARK REVDAT 2 07-JUN-17 5NQE 1 JRNL REVDAT 1 24-MAY-17 5NQE 0 JRNL AUTH K.UPTON,M.MEYERS,A.G.THORSELL,T.KARLBERG,J.HOLECHEK,R.LEASE, JRNL AUTH 2 G.SCHEY,E.WOLF,A.LUCENTE,H.SCHULER,D.FERRARIS JRNL TITL DESIGN AND SYNTHESIS OF POTENT INHIBITORS OF THE JRNL TITL 2 MONO(ADP-RIBOSYL)TRANSFERASE, PARP14. JRNL REF BIOORG. MED. CHEM. LETT. V. 27 2907 2017 JRNL REFN ESSN 1464-3405 JRNL PMID 28495083 JRNL DOI 10.1016/J.BMCL.2017.04.089 REMARK 2 REMARK 2 RESOLUTION. 2.71 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.3 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.71 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.18 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 14473 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.228 REMARK 3 R VALUE (WORKING SET) : 0.227 REMARK 3 FREE R VALUE : 0.258 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 724 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 7 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.71 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.93 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.40 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2956 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2815 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2808 REMARK 3 BIN R VALUE (WORKING SET) : 0.2798 REMARK 3 BIN FREE R VALUE : 0.3121 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.01 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 148 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2930 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 58 REMARK 3 SOLVENT ATOMS : 17 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 63.32 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 40.21 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.99260 REMARK 3 B22 (A**2) : -6.56220 REMARK 3 B33 (A**2) : 8.55480 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -1.36390 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.400 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.597 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.306 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.681 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.319 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.890 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.869 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3076 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 4178 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1354 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 100 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 444 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3076 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 380 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3401 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.12 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.18 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 2.98 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): -0.3191 -0.5443 16.9566 REMARK 3 T TENSOR REMARK 3 T11: -0.0557 T22: -0.0995 REMARK 3 T33: -0.1283 T12: -0.0161 REMARK 3 T13: -0.0093 T23: 0.0175 REMARK 3 L TENSOR REMARK 3 L11: 1.9494 L22: 1.1407 REMARK 3 L33: 3.1197 L12: -0.2106 REMARK 3 L13: 0.5917 L23: -0.0637 REMARK 3 S TENSOR REMARK 3 S11: -0.0563 S12: 0.0404 S13: 0.0719 REMARK 3 S21: 0.1055 S22: -0.0564 S23: -0.0326 REMARK 3 S31: -0.2565 S32: 0.2057 S33: 0.1127 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): 2.9808 33.1650 16.7188 REMARK 3 T TENSOR REMARK 3 T11: -0.0500 T22: -0.0921 REMARK 3 T33: -0.1306 T12: -0.0427 REMARK 3 T13: -0.0248 T23: -0.0106 REMARK 3 L TENSOR REMARK 3 L11: 1.7943 L22: 1.0986 REMARK 3 L33: 3.4641 L12: -0.2434 REMARK 3 L13: -0.3149 L23: 0.5295 REMARK 3 S TENSOR REMARK 3 S11: -0.0069 S12: -0.0623 S13: -0.0128 REMARK 3 S21: 0.1960 S22: -0.0607 S23: -0.0411 REMARK 3 S31: 0.2895 S32: -0.2692 S33: 0.0676 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5NQE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 21-APR-17. REMARK 100 THE DEPOSITION ID IS D_1200004540. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-MAR-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97625 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XIA2 REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14476 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.710 REMARK 200 RESOLUTION RANGE LOW (A) : 45.200 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 6.700 REMARK 200 R MERGE (I) : 0.28800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.71 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.87 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.5 REMARK 200 DATA REDUNDANCY IN SHELL : 6.50 REMARK 200 R MERGE FOR SHELL (I) : 1.15300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4F1L REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.06 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG3350, 0.2M SODIUM-MALONATE, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 41.71500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 45.18000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 41.71500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 45.18000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 1609 REMARK 465 MET A 1610 REMARK 465 ASP A 1611 REMARK 465 SER A 1700 REMARK 465 TYR A 1701 REMARK 465 ALA A 1702 REMARK 465 GLY A 1703 REMARK 465 LYS A 1704 REMARK 465 ASN A 1705 REMARK 465 ALA A 1706 REMARK 465 VAL A 1707 REMARK 465 ALA A 1708 REMARK 465 TYR A 1709 REMARK 465 SER B 1609 REMARK 465 MET B 1610 REMARK 465 ASP B 1611 REMARK 465 SER B 1700 REMARK 465 TYR B 1701 REMARK 465 ALA B 1702 REMARK 465 GLY B 1703 REMARK 465 LYS B 1704 REMARK 465 ASN B 1705 REMARK 465 ALA B 1706 REMARK 465 VAL B 1707 REMARK 465 ALA B 1708 REMARK 465 TYR B 1709 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O GLY B 1751 FBA 94Z B 1901 1.87 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 SER B1754 N - CA - CB ANGL. DEV. = -15.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A1637 2.35 -69.39 REMARK 500 ASP A1731 -167.78 -73.08 REMARK 500 ASN B1637 2.50 -69.34 REMARK 500 ASP B1731 -168.19 -73.21 REMARK 500 HIS B1753 16.55 -67.43 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 94Z A 1901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 94Z B 1901 DBREF 5NQE A 1611 1801 UNP Q460N5 PAR14_HUMAN 1611 1801 DBREF 5NQE B 1611 1801 UNP Q460N5 PAR14_HUMAN 1611 1801 SEQADV 5NQE SER A 1609 UNP Q460N5 EXPRESSION TAG SEQADV 5NQE MET A 1610 UNP Q460N5 EXPRESSION TAG SEQADV 5NQE SER B 1609 UNP Q460N5 EXPRESSION TAG SEQADV 5NQE MET B 1610 UNP Q460N5 EXPRESSION TAG SEQRES 1 A 193 SER MET ASP MET LYS GLN GLN ASN PHE CYS VAL VAL GLU SEQRES 2 A 193 LEU LEU PRO SER ASP PRO GLU TYR ASN THR VAL ALA SER SEQRES 3 A 193 LYS PHE ASN GLN THR CYS SER HIS PHE ARG ILE GLU LYS SEQRES 4 A 193 ILE GLU ARG ILE GLN ASN PRO ASP LEU TRP ASN SER TYR SEQRES 5 A 193 GLN ALA LYS LYS LYS THR MET ASP ALA LYS ASN GLY GLN SEQRES 6 A 193 THR MET ASN GLU LYS GLN LEU PHE HIS GLY THR ASP ALA SEQRES 7 A 193 GLY SER VAL PRO HIS VAL ASN ARG ASN GLY PHE ASN ARG SEQRES 8 A 193 SER TYR ALA GLY LYS ASN ALA VAL ALA TYR GLY LYS GLY SEQRES 9 A 193 THR TYR PHE ALA VAL ASN ALA ASN TYR SER ALA ASN ASP SEQRES 10 A 193 THR TYR SER ARG PRO ASP ALA ASN GLY ARG LYS HIS VAL SEQRES 11 A 193 TYR TYR VAL ARG VAL LEU THR GLY ILE TYR THR HIS GLY SEQRES 12 A 193 ASN HIS SER LEU ILE VAL PRO PRO SER LYS ASN PRO GLN SEQRES 13 A 193 ASN PRO THR ASP LEU TYR ASP THR VAL THR ASP ASN VAL SEQRES 14 A 193 HIS HIS PRO SER LEU PHE VAL ALA PHE TYR ASP TYR GLN SEQRES 15 A 193 ALA TYR PRO GLU TYR LEU ILE THR PHE ARG LYS SEQRES 1 B 193 SER MET ASP MET LYS GLN GLN ASN PHE CYS VAL VAL GLU SEQRES 2 B 193 LEU LEU PRO SER ASP PRO GLU TYR ASN THR VAL ALA SER SEQRES 3 B 193 LYS PHE ASN GLN THR CYS SER HIS PHE ARG ILE GLU LYS SEQRES 4 B 193 ILE GLU ARG ILE GLN ASN PRO ASP LEU TRP ASN SER TYR SEQRES 5 B 193 GLN ALA LYS LYS LYS THR MET ASP ALA LYS ASN GLY GLN SEQRES 6 B 193 THR MET ASN GLU LYS GLN LEU PHE HIS GLY THR ASP ALA SEQRES 7 B 193 GLY SER VAL PRO HIS VAL ASN ARG ASN GLY PHE ASN ARG SEQRES 8 B 193 SER TYR ALA GLY LYS ASN ALA VAL ALA TYR GLY LYS GLY SEQRES 9 B 193 THR TYR PHE ALA VAL ASN ALA ASN TYR SER ALA ASN ASP SEQRES 10 B 193 THR TYR SER ARG PRO ASP ALA ASN GLY ARG LYS HIS VAL SEQRES 11 B 193 TYR TYR VAL ARG VAL LEU THR GLY ILE TYR THR HIS GLY SEQRES 12 B 193 ASN HIS SER LEU ILE VAL PRO PRO SER LYS ASN PRO GLN SEQRES 13 B 193 ASN PRO THR ASP LEU TYR ASP THR VAL THR ASP ASN VAL SEQRES 14 B 193 HIS HIS PRO SER LEU PHE VAL ALA PHE TYR ASP TYR GLN SEQRES 15 B 193 ALA TYR PRO GLU TYR LEU ILE THR PHE ARG LYS HET 94Z A1901 29 HET 94Z B1901 29 HETNAM 94Z 3-[[4-[4-(4-FLUOROPHENYL)PIPERAZIN-1-YL]-4- HETNAM 2 94Z OXIDANYLIDENE-BUTANOYL]AMINO]BENZAMIDE FORMUL 3 94Z 2(C21 H23 F N4 O3) FORMUL 5 HOH *17(H2 O) HELIX 1 AA1 ASP A 1626 ASN A 1637 1 12 HELIX 2 AA2 ASN A 1653 ALA A 1669 1 17 HELIX 3 AA3 ASP A 1685 GLY A 1687 5 3 HELIX 4 AA4 SER A 1688 GLY A 1696 1 9 HELIX 5 AA5 ASN A 1718 ALA A 1723 1 6 HELIX 6 AA6 ASP B 1626 ASN B 1637 1 12 HELIX 7 AA7 ASN B 1653 ALA B 1669 1 17 HELIX 8 AA8 ASP B 1685 GLY B 1687 5 3 HELIX 9 AA9 SER B 1688 GLY B 1696 1 9 HELIX 10 AB1 ASN B 1718 ALA B 1723 1 6 SHEET 1 AA1 5 CYS A1618 GLU A1621 0 SHEET 2 AA1 5 ARG A1644 GLN A1652 -1 O ARG A1650 N VAL A1620 SHEET 3 AA1 5 ALA A1791 ARG A1800 -1 O THR A1798 N LYS A1647 SHEET 4 AA1 5 LYS A1736 LEU A1744 -1 N LYS A1736 O PHE A1799 SHEET 5 AA1 5 GLU A1677 THR A1684 -1 N LYS A1678 O VAL A1743 SHEET 1 AA2 4 THR A1713 ALA A1716 0 SHEET 2 AA2 4 LEU A1782 ALA A1785 -1 O PHE A1783 N PHE A1715 SHEET 3 AA2 4 THR A1772 THR A1774 -1 N VAL A1773 O VAL A1784 SHEET 4 AA2 4 TYR A1748 HIS A1750 1 N THR A1749 O THR A1774 SHEET 1 AA3 2 SER A1760 ASN A1762 0 SHEET 2 AA3 2 ASN A1765 LEU A1769 -1 O ASP A1768 N LYS A1761 SHEET 1 AA4 5 CYS B1618 GLU B1621 0 SHEET 2 AA4 5 ARG B1644 GLN B1652 -1 O ARG B1650 N VAL B1620 SHEET 3 AA4 5 ALA B1791 ARG B1800 -1 O ARG B1800 N ARG B1644 SHEET 4 AA4 5 LYS B1736 LEU B1744 -1 N LYS B1736 O PHE B1799 SHEET 5 AA4 5 GLU B1677 THR B1684 -1 N LYS B1678 O VAL B1743 SHEET 1 AA5 4 THR B1713 ALA B1716 0 SHEET 2 AA5 4 LEU B1782 ALA B1785 -1 O PHE B1783 N PHE B1715 SHEET 3 AA5 4 THR B1772 THR B1774 -1 N VAL B1773 O VAL B1784 SHEET 4 AA5 4 TYR B1748 HIS B1750 1 N THR B1749 O THR B1774 SSBOND 1 CYS A 1618 CYS A 1618 1555 2555 2.04 SSBOND 2 CYS B 1618 CYS B 1618 1555 2555 2.04 SITE 1 AC1 15 HIS A1682 GLY A1683 TYR A1714 PHE A1715 SITE 2 AC1 15 ALA A1716 TYR A1721 SER A1722 TYR A1727 SITE 3 AC1 15 GLY A1751 ASN A1752 HIS A1753 THR A1774 SITE 4 AC1 15 LEU A1782 VAL A1784 94Z B1901 SITE 1 AC2 13 94Z A1901 HIS B1682 GLY B1683 TYR B1714 SITE 2 AC2 13 PHE B1715 ALA B1716 TYR B1721 SER B1722 SITE 3 AC2 13 TYR B1727 GLY B1751 THR B1774 LEU B1782 SITE 4 AC2 13 VAL B1784 CRYST1 83.430 90.360 80.070 90.00 116.42 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011986 0.000000 0.005955 0.00000 SCALE2 0.000000 0.011067 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013946 0.00000